Bernstein, Needham, and Keybanc analysts have raised their price targets for Robinhood Markets, reflecting increased confidence in the financial services platform's valuation outlook. Bernstein analyst Gautam Chhugani maintained an Outperform rating with a new target of $160, up from $130. Keybanc analyst Alex Markgraff maintained an Overweight rating and raised the target to $125 from $100. Needham's John Todaro kept a Buy rating and increased the target to $123 from $97. The adjustments suggest updated assessments of the company's future earnings and market position.

Analyst Ratings and Price Targets

The research notes from all three firms reinforce positive sentiment toward Robinhood Markets' performance potential. The decisions to maintain Outperform, Overweight, and Buy ratings align with the analysts' stances on the stock's trajectory.

Robinhood Markets, Inc. has introduced the Robinhood Platinum Card, featuring Function as a core benefit to address the growing trend of treating health as a long-term asset. Eligible cardholders receive a complimentary annual Function membership, valued at $365, which includes access to more than 160 lab tests. This initiative reflects a shift in consumer spending, as health and wellness remain a category where Americans plan to increase spending in 2026.

The partnership aims to bridge the gap between financial and physical well-being. Function membership provides biannual testing, clinician-reviewed results, and a centralized platform for health data. The benefit is designed to make comprehensive health monitoring, previously associated with high-cost executive physicals, accessible to a broader audience.

"Shaping your future means more than just investing your money," said Sanjay Kotte, Chief Commercial Officer at Robinhood Money. "Bringing Function Health to the Robinhood Platinum Card reflects our belief that managing your health is just as important as managing your wealth."

The Robinhood Platinum Card is issued by Coastal Community Bank pursuant to a license from Visa U.S.A. Inc., while Robinhood Credit, Inc. acts as the financial technology company facilitating the offer. The card is currently available on an invite-only basis, with access requests managed through the Robinhood platform.

"A healthy person has a thousand wishes. A sick person has one," said Jonathan Swerdlin, Co-Founder and CEO at Function. "Robinhood has given millions the power to own their finances... Function has done the same for health."